BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.51% | 11.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.51% | 11.05% | |||
| Cost of Revenue | 1.75% | 8.17% | |||
| Gross Profit | 4.52% | 12.76% | |||
| SG&A Expenses | -8.54% | 9.43% | |||
| Depreciation & Amortization | 84.71% | 28.79% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.56% | 10.58% | |||
| Operating Income | 6,181.48% | 133.75% | |||
| Income Before Tax | 120.59% | -35.50% | |||
| Income Tax Expenses | -68,408.06% | 135.84% | |||
| Earnings from Continuing Operations | 3,703.04% | -43.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3,703.04% | -89.29% | |||
| EBIT | 6,181.48% | 133.75% | |||
| EBITDA | 245.04% | 43.48% | |||
| EPS Basic | 3,667.35% | -89.34% | |||
| Normalized Basic EPS | 142.76% | -42.23% | |||
| EPS Diluted | 4,450.00% | -91.02% | |||
| Normalized Diluted EPS | 144.06% | -42.11% | |||
| Average Basic Shares Outstanding | 0.84% | 0.65% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||